4.7 Article

A molecularly imprinted electrochemical sensor based on highly selective and an ultra-trace assay of anti-cancer drug axitinib in its dosage form and biological samples

期刊

TALANTA
卷 233, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.talanta.2021.122569

关键词

Axitinib; Molecularly imprinted polymer; o-phenylenediamine; Electrochemical determination; Voltammetry; Drug analysis

资金

  1. Council of Higher Education 100/2000 (YOK)
  2. Scientific and Technological Research Council of Turkey (TUBITAK)

向作者/读者索取更多资源

A novel MIP-based electrochemical sensor was developed for the determination of low concentrations of AXI in pharmaceutical dosage forms and human serum. The sensor showed significant selectivity and sensitivity towards AXI, making it suitable for analysis of tablet dosage forms and human serum samples.
In this study, a novel, fast, selective, and sensitive molecularly imprinted polymer (MIP)-based electrochemical sensor was developed to determine axitinib (AXI) at low concentrations in pharmaceutical dosage forms and human serum. The newly developed MIP-based sensor (MIP@o-PD/GCE) was designed through electro-polymerization of functional monomer o-phenylenediamine (o-PD) in the presence of a template molecule AXI, on a glassy carbon electrode (GCE) using cyclic voltammetry. Differential pulse voltammetry and electrochemical impedance spectroscopy (EIS) techniques were employed for removal and rebinding processes, optimization of conditions, as well as for performance evaluation of MIP@o-PD/GCE using [Fe(CN)(6)](3-/4-) as the redox probe. Under the optimum experimental conditions, MIP@o-PD/GCE shows a linear response toward AXI in a range of 1 x 10(-13) M-1 x 10(-12) M. The limit of the detection value of MIP@o-PD/GCE was found as 0.027 pM while the limit of the quantification was obtained as 0.089 pM, respectively. To demonstrate the applicability and validity of the developed sensor, it was successfully applied to tablet dosage form and human serum sample. The selectivity of the sensor was qualified by comparing the binding of AXI, erlotinib, dasatinib, nilotinib, and imatinib, which are similarly structured and in the same group of anticancer drugs. MIP@o-PD/GCE sensor showed a significant selectivity toward AXI. The non-imprinted polymer (NIP) based GCE was prepared and used to control the analytical performance of the MIP-based electrochemical sensor.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据